ViewSocieties warn of exclusive Covid-19 focus

Medical research not related to the pandemic has taken a hit, say scientists

ViewSeven UK Covid vaccine efforts you may not have heard of

The race is still on for vaccines that could tackle coronavirus variants in different ways

ViewLSE takes out £80m loan to help fight Covid-19 ‘challenge’

Several universities take advantage of short-term debt offer to ease Covid-19 pressures

ViewEU approves Johnson & Johnson vaccine for Covid-19

Commission expects 200 million doses to be delivered from second quarter of the year

ViewReviewers of Covid papers play the good cop

The pandemic has turned reviewers from gatekeepers into coaches, says Serge Horbach

View€750bn Covid recovery fund harnessed to bolster ‘most promising’ R&D areas

Economists warn national governments should use money to bring lasting change to research capacity

ViewUniversities deny accusation they are ‘flouting’ Covid rules

Three institutions reject claims they are not following government guidance

ViewRectors demand rapid Covid-19 tests at universities

Academia seeks to be treated like companies and schools in plan to ease German lockdown

ViewAustria, Denmark and Israel to launch joint Covid-19 R&D fund

Leaders of three countries pledge cooperation on R&D and vaccine production

ViewDrug regulators to ‘fast-track vaccines for new Covid variants’

Australia, Canada, Singapore, Switzerland and UK issue guidance to ensure future vaccines are available quickly

ViewHardy: Covid-19 impact on student mental health ‘inevitable’

Shadow minister warns of worsening picture for students on University Mental Health Day

ViewStrong patent growth avoids Covid-19 damper

China shows strength in university and company patent applications in 2020

ViewSouth Africa’s Covid-19 variant protects against other strains

Finding could lead to vaccines effective against all circulating variants

ViewNUS Wales: Covid problems to ‘last for years’

Conference hears of issues facing students during pandemic

ViewDrug companies and MEPs wade into IP battle around Covid-19

Debate intensifies over whether intellectual property should be waived for treatments and vaccines

ViewNasal spray joins race for easier-to-use Covid vaccine

Lancaster team touts another contender in quest for easier administration of coronavirus vaccinations

ViewQuarter of students and graduates say Covid-19 skewed career plans

Survey finds pandemic has forced a change of direction for some students’ careers

ViewFree Covid-19 toolkit to aid researchers worldwide

Resources partly developed in Australia enable researchers to ‘determine how drug candidates affect virus replication’

ViewScience budget recovers from Covid cuts

NRF gets back to pre-pandemic totals, but unclear where money will go

ViewInterview: Coordinating Covid

Charu Kaushic on lessons learned from chairing a global network of funders through the pandemic

ViewFears for dropout rates as Covid blocks access to social activities

Working-class students more at risk of missing out on clubs and internships, Sutton Trust says

ViewCovid-19: Spain sets aside €34m to extend researchers’ contracts

Minister says ‘all extension requests granted’, with future requests to be approved once received

ViewHalf of students in some halls infected with Covid last year

Highest antibody levels among students in halls, with one in five of all students infected

ViewExperts query Johnson’s Covid reopening roadmap

Details missing on tests, travel and tracing system for the UK, scientists say

ViewSage warning over student returns and Covid-19

Scientific advisory group also warns over effectiveness of lateral flow tests

ViewHow a UK firm put a Covid-19 vaccine in a pill

Wayne Channon, head of iosBio, on starting with Innovate UK money before turning to America

ViewMPs hear call for vaccine-like taskforce for Covid-19 antivirals

Experts identify antiviral drugs and testing system as weak link in country’s anti-Covid fight

ViewHow South Africa could have handled Covid-19 better

Policing and preparedness criticised in pandemic response

ViewDevelopment partnerships: post-Covid, post-Brexit, post-DfID

Assessing the impact of a triple threat to those working in development and aid-related fields

ViewUK to conduct first Covid-19 human challenge study

Study announced as US scientists detect merger of two variants into ‘heavily mutated coronavirus’